Navigation Links
Scioderm's Investigational New Drug (IND) Application for SD-101 for Treatment of Epidermolysis Bullosa (EB) Allowed by the FDA
Date:2/13/2013

RALEIGH, N.C., Feb. 13, 2013 /PRNewswire-iReach/ -- Scioderm announced that the US Food and Drug Administration (FDA) has reviewed and allowed the investigational new drug (IND) application for SD-101 to proceed.  SD-101 is a topical treatment being developed for the treatment of Epidermolysis Bullosa (EB).  The Company plans to initiate a Phase 1 study in the coming months, with initiation of the Phase 2B/3 study in EB patients to occur in the second half of 2013. 

EB is a rare genetic condition that in all of its forms, share the prominent manifestation of extremely fragile skin that blisters or tears with the slightest friction or trauma.  The disease affects not only the skin but also many internal organs and bodily systems.  This particular manifestation has led to EB patients being known as Butterfly children due to the analogous nature of the fragility of the skin to the wings of a butterfly.  As of today there is no cure or effective treatment.  Wound care, pain management and preventative bandaging are the only options available for caregivers, usually the parents or other family members.  The more severe forms of the disease lead to scarring, disfigurement, disability and early death, usually before the age of 30. 

"We are excited to reach this important corporate milestone and to advance this novel therapy in the clinic," stated Robert Ryan , Ph.D., Chairman of the Board and Co-Founder of Scioderm.  "We look forward to continuing our rapid development of this program to treat a disease where there are no current effective therapies.  In addition, we look forward to working closely with the FDA to expedite the continuing clinical testing and regulatory review of SD-101." 

 "I am enthused by the results SD-101 has demonstrated and with the rapid progress Scioderm has achieved in bringing this potential treatment
'/>"/>

SOURCE Scioderm
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sanofi Pasteur Presents Pediatric Data on Investigational Quadrivalent Influenza Vaccine
2. Data from Study of Elderly Depressed Patients are Reported for Investigational Compound Lu AA21004 on Symptoms of Major Depressive Disorder (MDD)
3. Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor
4. Results of Phase II Study of Boehringer Ingelheims Investigational Bronchodilator for COPD Presented at 2012 ATS International Conference
5. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
6. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
7. Abbott Presents Results of Clinical Studies Evaluating Its Investigational Treatment for Advanced Parkinsons Disease
8. Results For Phase 2b Trial Of Unique Investigational Cell-Based Therapy In Venous Leg Ulcers Published In The Lancet
9. Janssen Biotech Announces Global License and Development Agreement for Investigational Anti-Cancer Agent Daratumumab
10. Clinical Study With Investigational Cream Aims To Help Women Who Experience Painful Sex
11. Omeros Files Investigational New Drug Application for Lead Compound in PDE10 Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... 2, 2015   Oriel STAT A MATRIX ... covering the most critical compliance and performance issues ... device manufacturers are experiencing an industry-transforming level of ... products, and global supply chains are negatively impacting ... and global regulators are increasing compliance requirements, scrutiny, ...
(Date:3/2/2015)... 2015  Kush Bottles, North America,s ... for the marijuana industry, announced today that its CEO ... nominated for a 2015 Excellence in Entrepreneurship Award.  ... is designed to recognize individuals who exemplify the ... creativity and determination, have established and nurtured successful ...
(Date:3/2/2015)... , March 2, 2015  Maquet Medical ... that it has signed an exclusive distribution agreement ... Medical,s flagship product, the Flight 60 mechanical ventilator. ... technology, providing dependable and affordable mobility. Starting in ... will be sold in the United ...
Breaking Medicine Technology:Oriel STAT A MATRIX Announces New Professional Certification Programs for Medical Device Regulatory and Quality Assurance Professionals 2Oriel STAT A MATRIX Announces New Professional Certification Programs for Medical Device Regulatory and Quality Assurance Professionals 3Kush Bottles CEO, Nicholas Kovacevich, Nominated for 2015 "Excellence in Entrepreneurship Award" 2Maquet Medical Systems USA to Exclusively Distribute Flight Medical's Flight 60 Respiratory Ventilators 2Maquet Medical Systems USA to Exclusively Distribute Flight Medical's Flight 60 Respiratory Ventilators 3
... Oct. 26 Accuray,Incorporated (Nasdaq: ARAY ), ... today that the company is partnering with The ... Houston, Texas to launch a prospective,clinical study to ... in the study will be randomly assigned to ...
... announces data presented at AACR-NCI-EORTC ... ... (CTI) (Nasdaq and MTAX: CTIC) and Systems Medicine, LLC (SM), a,wholly-owned ... candidates during the 19th annual AACR-NCI-EORTC Symposium. "These studies show ...
Cached Medicine Technology:M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife(R) Radiosurgery for Operable Lung Cancer Patients 2M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife(R) Radiosurgery for Operable Lung Cancer Patients 3M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife(R) Radiosurgery for Operable Lung Cancer Patients 4Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development 2Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development 3Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development 4Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development 5
(Date:3/2/2015)... (PRWEB) March 02, 2015 Today ... Luis Obispo), in partnership with the California Healthcare ... Disorders (NORD), presented an Assembly resolution recognizing Feb. ... families and healthcare professionals caring for millions of ... is a nonprofit, public policy research organization, representing ...
(Date:3/2/2015)... 2015 Today the Brain Injury Association of ... time to recognize and support the more than 5.3 million ... year BIAA leads the nation in observing Brain Injury Awareness ... March. The theme for the 2015 to 2017 campaign is: ... platform for educating the general public about the incidence of ...
(Date:3/2/2015)... March 02, 2015 A cocaine ... deviating from the typical nip slip or scathing scuffle. ... industry is dawning the streets of Hollywood as Paper ... about drug addiction and substance abuse in Hollywood. The ... to take a political stance on the travails of ...
(Date:3/2/2015)... “ Wants and Needs ” was ... which features the latest and coolest mobile applications on ... mobile technology expert and host of NewsWatch, conducted the ... helps people evaluate priorities. , Whether a person needs ... Needs app. The app allows people to enter and ...
(Date:3/2/2015)... OR (PRWEB) March 02, 2015 ... plan to remake American healthcare. Zoom will expand ... 28 neighborhood clinics and advanced care studios delivering ... health, emergency services, specialty care and outpatient surgery. ... on-demand access to almost all healthcare needs outside ...
Breaking Medicine News(10 mins):Health News:California Healthcare Institute Spotlights Impact of Rare Diseases with Assemblymember Katcho Achadjian 2Health News:California Healthcare Institute Spotlights Impact of Rare Diseases with Assemblymember Katcho Achadjian 3Health News:Brain Injury Association of America Launches “Not Alone” Campaign for Brain Injury Awareness Month 2Health News:Oscar Statue Snorting Cocaine Catches All Eyes in Hollywood, Ca 2Health News:Oscar Statue Snorting Cocaine Catches All Eyes in Hollywood, Ca 3Health News:An Application to Evaluate Priorities Was Featured on NewsWatch Television on January 30, 2015 2Health News:ZoomCare Announces 28-Location, On-Demand Neighborhood Health Campus 2Health News:ZoomCare Announces 28-Location, On-Demand Neighborhood Health Campus 3
... HealthDay Reporter , WEDNESDAY, July 6 (HealthDay News) ... and linked to increased rates of potentially dangerous low ... drug was approved in 2001 to help heart failure ... severe shortness of breath. But the drug had no ...
... expanded access to health care facilitated by health care reform ... and other advanced medical professionals. According to a study published ... American College of Surgeons, the United States will face ... nurses, and physician assistants over the next two decades. The ...
... WEDNESDAY, July 6 (HealthDay News) -- Simpler and shorter ... in millions of people worldwide infected with the bacterium ... researchers report. TB, or tuberculosis, is the leading ... virus that causes AIDS. About half a million people ...
... , WEDNESDAY, July 6 (HealthDay News) -- Move over, Lyme ... parts of the country, and this one can kill. ... parasite that attacks blood cells, causing flu-like symptoms that can ... is caused by bacteria, babesia microti parasites are carried by ...
... in The Journal of Sexual Medicine reveals ... physical inactivity, high alcohol consumption, tobacco smoking, and hard ... an unhealthy lifestyle is more common in persons who ... Frisch, MD, PhD, DSc, of Statens Serum Institut, used ...
... Ga. Altering the body,s metabolism could be an ... The finding that inhibiting heat shock transcription factor 1, ... another wake-up call that a low-fat, healthy diet is ... Virologist/Immunologist at Georgia Health Sciences University. HSF1 and its ...
Cached Medicine News:Health News:Study Finds Heart Failure Drug Ineffective 2Health News:Study Finds Heart Failure Drug Ineffective 3Health News:Study Finds Heart Failure Drug Ineffective 4Health News:Future labor shortfalls of medical professionals predicted due to new demands of health-care reform 2Health News:New Combo Therapy May Prevent TB, Save Lives in People With HIV 2Health News:A Deadly New Reason to Avoid Deer Ticks 2Health News:A Deadly New Reason to Avoid Deer Ticks 3Health News:An unhealthy lifestyle is associated with sexual dysfunction 2Health News:Transcription factor is potential target for liver cancer treatment 2
2.0mm Rounded Tip, 12mm From Tip to Bend Gently Curved, 15mm Shaft; In Titanium...
0.5X2.0mm Tip, Oval Shape; in Titanium....
Bend with "H" Shaped Tip, LEFT; in Titanium....
Lightly Curved-Blunt Tips Rounded Blades; 1mm Eye in Blades; 27mm from mid screw to tip. Matte finish; Stainless Steel, overall length 120mm...
Medicine Products: